Regadenoson Injection
Product Images NDC 43598-616

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 43598-616). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

This is a description of a medication called Regadenoson Injection used as a Pharmacologic Stress Agent for Diagnostic Purposes. It comes in a prefilled syringe with 0.4 mg/5 mL and should be injected intravenously within 10 seconds, followed by saline flush and radiopharmaceutical. The medication contains 0.08 mg regadenoson, 10 mg dibasic sodium phosphate, 5. mg monobasic sodium phosphate, 150 mg propylene glycol, 1mg edetate disodium, hydrate, and water for injection. It should be stored at 20-26°C. Syringes may require needle or blunt. The text also provides some technical information about the packaging and storage.*

FDA Label Image

Pfs (Pfs)

This is a description of a medication called Regadenoson Injection, which comes in a single-use vial of 5mL with a strength of 0.4mg/5mL (0.08mg/mL). It is intended for Pharmacologic Stress via intravenous use only and requires a prescription (Rx Only). The medication is distributed by Dr. Reddy's Laboratories Inc. with a manufacturing location in India with a code number of AP/DRUGS/103/97 and an expiration date of 1/11/2022.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.